Designing drugs when there is low data availability: one-shot learning and other approaches to face the issues of a long-term concern
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 30, 2022 Category: Drugs & Pharmacology Authors: Gabriel C. Ver íssimo Mateus S á M. Serafim Thales Kronenberger Rafaela S. Ferreira Kathia M. Honorio Vin ícius G. Maltarollo Source Type: research
Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 30, 2022 Category: Drugs & Pharmacology Authors: Alane Beatriz Vermelho Giseli Capaci Rodrigues Alessio Nocentini Felipe R. P. Mansoldo Claudiu T. Supuran Source Type: research
Role of computational and structural biology in the development of small-molecule modulators of the spliceosome
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 24, 2022 Category: Drugs & Pharmacology Authors: Riccardo Rozza Pavel Jano š Angelo Spinello Alessandra Magistrato Source Type: research
Recent advances in cellular models for discovering prion disease therapeutics
Volume 17, Issue 9, September 2022, Page 985-996 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 24, 2022 Category: Drugs & Pharmacology Authors: Lea Nikoli ć Chiara Ferracin Giuseppe Legname Source Type: research
Role of computational and structural biology in the development of small-molecule modulators of the spliceosome
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 24, 2022 Category: Drugs & Pharmacology Authors: Riccardo Rozza Pavel Jano š Angelo Spinello Alessandra Magistrato Source Type: research
Recent advances in cellular models for discovering prion disease therapeutics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 24, 2022 Category: Drugs & Pharmacology Authors: Lea Nikoli ć Chiara Ferracin Giuseppe Legname Source Type: research
Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 23, 2022 Category: Drugs & Pharmacology Authors: Andrzej Pilc Agata Machaczka Pawe ł Kawalec Jodi L. Smith Jeffrey M. Witkin Source Type: research
Metabolomics in antimicrobial drug discovery
Volume 17, Issue 9, September 2022, Page 1047-1059 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 23, 2022 Category: Drugs & Pharmacology Authors: Rustam Aminov Source Type: research
Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery
Volume 17, Issue 9, September 2022, Page 1013-1027 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 23, 2022 Category: Drugs & Pharmacology Authors: Mohammad Feyzizadeh Ashkan Barfar Zeinab Nouri Muhammad Sarfraz Parvin Zakeri-Milani Hadi Valizadeh Source Type: research
Metabolomics in antimicrobial drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 23, 2022 Category: Drugs & Pharmacology Authors: Rustam Aminov Source Type: research
Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 23, 2022 Category: Drugs & Pharmacology Authors: Mohammad Feyzizadeh Ashkan Barfar Zeinab Nouri Muhammad Sarfraz Parvin Zakeri-Milani Hadi Valizadeh Source Type: research
Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 23, 2022 Category: Drugs & Pharmacology Authors: Andrzej Pilc Agata Machaczka Pawe ł Kawalec Jodi L. Smith Jeffrey M. Witkin Source Type: research
Strategies for targeting RNA with small molecule drugs
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 18, 2022 Category: Drugs & Pharmacology Authors: Christopher L. Haga Donald G. Phinney Source Type: research
Structure-activity relationships of Toxoplasma gondii cytochrome bc1 inhibitors
Volume 17, Issue 9, September 2022, Page 997-1011 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 9, 2022 Category: Drugs & Pharmacology Authors: P. Holland Alday Aaron Nilsen J. Stone Doggett Source Type: research
